Suprima II Model 254-28
by Intermedics, Inc. 510(k)
Active
510(k) K852432
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK852432 | Date17 Jul 1985 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- DXY
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3610
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Suprema II Model 254-28 is an Implantable Pacemaker Pulse-Generator, a Class III medical device designed to regulate cardiac rhythm by delivering electrical impulses to the heart when spontaneous contractions are insufficient. It is intended for patients requiring permanent pacing to manage bradycardia or other conduction disorders.
This device is supplied sterile and intended for single-use implantation, adhering to FDA 510(k) clearance (K852432) under regulation 870.3610. It is classified under the product code DXY and reviewed by the Cardiovascular Advisory Committee. Storage and handling must comply with sterile medical device protocols, and its use is governed by the original FDA authorization from 1985.
Other devices from Intermedics, Inc.
Questions
AI-generated answers, 18 Sep 2026
What is the primary clinical purpose of the Suprema II Model 254-28 pacemaker, and who is it designed for?
The Suprema II Model 254-28 is an implantable pacemaker pulse-generator designed to regulate cardiac rhythm by delivering electrical impulses to the heart when natural contractions are insufficient. It is intended for patients who require permanent pacing to manage bradycardia or conduction disorders, ensuring consistent heart function when spontaneous beats are inadequate.
Is this device intended for single-use or reusable implantation, and how should it be handled?
The Suprema II Model 254-28 is supplied sterile and intended for single-use implantation only. Since it is sterile, it must be handled according to strict sterile medical device protocols to prevent contamination before use.
What regulatory pathway was followed for FDA clearance of this device, and which advisory committee reviewed it?
The Suprema II Model 254-28 received FDA clearance through a Traditional 510(k) review under the product code DXY, with a decision of *Substantially Equivalent* (SESE). It was reviewed by the Cardiovascular (CV) Advisory Committee and originally authorized in 1985 under regulation 870.3610.
How should this device be stored to maintain its integrity before implantation?
Since the Suprema II Model 254-28 is sterile and intended for single-use, it must be stored in accordance with sterile medical device protocols. This typically includes keeping it in its original packaging, in a clean, dry environment, and away from extreme temperatures or contamination until immediate use.